TABLE 1.
The correlation between NMI mRNA and anticancer drug sensitivity based on RNAactDrug data. ***p < 0.001.
| Compound | RNAtype | RNAmoleade | Omits | Source | Peanon stat | Pearson.fdr | Spearmanstat | Spearman.dr |
|---|---|---|---|---|---|---|---|---|
| Pcliainib | mRNA | NMI | Expression | GDSC | −0.2490565 | *** | 0.2946408 | *** |
| Bosutinib | mRNA | NMI | Expression | GDSC | −0.2363505 | *** | 0.2504253 | *** |
| AICA Ribonueleotide | mRNA | NMI | Expression | GDSC | −0.1681221 | *** | 0.2137404 | *** |
| WH1-P97 | mRNA | NMI | Expression | GDSC | −0.1927539 | *** | 0.2270336 | *** |
| Idelalisib | mRNA | NMI | Expression | GDSC | −0.2039266 | *** | 0.2024053 | *** |
| B1X02189 | mRNA | NMI | Expression | GDSC | −0.1779594 | *** | 0.1952747 | *** |
| TPCA-I | mRNA | NMI | Expression | GDSC | −0.1651384 | *** | 0.1916956 | *** |
| AICA Ribonueleotide | mRNA | NMI | Methylation | GDSC | 0.14491277 | *** | 0.20265865 | *** |
| Afatinib | mRNA | NMI | Expression | GDSC | 0.1400821 | *** | 0.1960697 | *** |
| SNX-2112 | mRNA | NMI | Expression | GDSC | 0.1475029 | *** | 0.1897817 | *** |
| AT-7519 | mRNA | NMI | Expression | GDSC | 0.1375211 | *** | 0.1839012 | *** |
| FR-180204 | mRNA | NMI | Expression | GDSC | 0.1633403 | *** | 0.1868138 | *** |
| Methotrexate | mRNA | NMI | Expression | GDSC | 0.1434948 | *** | 0.1811458 | *** |
| Enzastaurin | mRNA | NMI | Expression | GDSC | 0.1733262 | *** | 0.1966106 | *** |
| OSU-03012 | mRNA | NMI | Expression | GDSC | 0.1685606 | *** | 0.2017743 | *** |
| AZD7762 | mRNA | NMI | Methylation | GDSC | 0.14467147 | *** | 0.19235985 | *** |
| Gcmciaabine | mRNA | NMI | Expression | GDSC | 0.1880426 | *** | 0.2103153 | *** |
| AS605240 | mRNA | NMI | Expression | GDSC | 0.1577792 | *** | 0.1876233 | *** |
| ZSTK474 | mRNA | NMI | Expression | GDSC | 0.1659785 | *** | 0.182499 | *** |
| CP466722 | mRNA | NMI | Expression | GDSC | 0.1495175 | *** | 0.1771389 | *** |